Optimizing adjuvant therapy and survivorship care of stage III colon cancer. - Wikidata - awgldk - TriplyDB

Optimizing adjuvant therapy and survivorship care of stage III colon cancer.

Optimizing adjuvant therapy and survivorship care of stage III colon cancer.

http://www.wikidata.org/entity/Q30249616

about

A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy

P2860

Q58584090-6BAECCD7-384D-4633-913B-A89756E54D3B

P2860

Optimizing adjuvant therapy and survivorship care of stage III colon cancer.

http://www.wikidata.org/entity/Q30249616

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Optimizing adjuvant therapy and survivorship care of stage III colon cancer.

@ast

Optimizing adjuvant therapy and survivorship care of stage III colon cancer.

@en

type

label

Optimizing adjuvant therapy and survivorship care of stage III colon cancer.

@ast

Optimizing adjuvant therapy and survivorship care of stage III colon cancer.

@en

prefLabel

Optimizing adjuvant therapy and survivorship care of stage III colon cancer.

@ast

Optimizing adjuvant therapy and survivorship care of stage III colon cancer.

@en

P1433

Q30249616-885112F4-D843-44C8-9EB6-C08F8D747A83

P1476

Q30249616-6739CAD7-636F-48D8-8E23-BA4A148527C2

P2093

Q30249616-BCD290A1-2BC8-4BF1-B5B1-DBE5F4C264B3

P2860

Q30249616-0126C472-A1B4-4E45-B33C-7DDD3C47ADAA

Q30249616-05EC0874-F89F-4B85-B62E-384A81222AEC

Q30249616-09B8F8AC-3023-465C-90CF-E4D240E3383B

Q30249616-0BE7001D-2D83-443B-9B19-5760F0064940

Q30249616-0C0F2D99-0963-4FC7-9A48-52B63B9D47DC

Q30249616-167053F7-307C-4B0B-94F5-13C130DE3B18

Q30249616-19B76A22-A645-4A39-9A22-0ADBB24F5093

Q30249616-1D8270E8-A855-4E24-9A09-47FEDD5E7246

Q30249616-215A1410-3094-4703-80F0-737FBE764D64

Q30249616-21AF2B28-A458-4D7C-897E-842BF1301535

P304

Q30249616-5DAE8A26-938E-4B4F-8284-B72CB3946970

P31

Q30249616-14457A72-AFE9-49FE-9493-FC385B364ADC

P356

Q30249616-E3F1DFA7-C723-44F1-A183-6DA3452B340B

P407

Q30249616-198FBA53-B255-41F7-9314-0E341E336F58

P433

Q30249616-E92AE19E-585C-4B0D-9CBE-FB5476143BF5

P478

Q30249616-544598B7-4109-4585-965E-F3DDB2780264

P50

Q30249616-44A1E6BC-F3D0-4396-99B6-88B79C2EA29D

P577

Q30249616-15F87367-1EE1-4CD6-9FA5-4BF8131A0352

P698

Q30249616-DC050578-CFDA-4700-B824-546B57B3AA97

P356

P1433

Future Oncology

P1476

Optimizing adjuvant therapy and survivorship care of stage III colon cancer

@en

P2093

Winson Y Cheung

http://www.w3.org/2001/XMLSchema#string

P2860

The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force

The real cost of sequencing: scaling computation to keep pace with data generation

The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 mont

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised co

Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.

Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer

Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials.

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

P304

2021-2035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2016-0109

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan M Loree

P577

2016-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27301775

http://www.w3.org/2001/XMLSchema#string